BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17276463)

  • 21. Participation of non-neuronal muscarinic receptors in the effect of carbachol with paclitaxel on human breast adenocarcinoma cells. Roles of nitric oxide synthase and arginase.
    Español AJ; Salem A; Rojo D; Sales ME
    Int Immunopharmacol; 2015 Nov; 29(1):87-92. PubMed ID: 25812766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M(1) and M(2) muscarinic acetylcholine receptor subtypes mediate Ca(2+) channel current inhibition in rat sympathetic stellate ganglion neurons.
    Yang Q; Sumner AD; Puhl HL; Ruiz-Velasco V
    J Neurophysiol; 2006 Nov; 96(5):2479-87. PubMed ID: 17005606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
    Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
    Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferative actions of muscarinic receptors expressed in macrophages derived from normal and tumor bearing mice.
    de la Torre E; Genaro AM; Ribeiro ML; Pagotto R; Pignataro OP; Sales ME
    Biochim Biophys Acta; 2008 Feb; 1782(2):82-9. PubMed ID: 18078830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinergic activation of phasic activity in the isolated bladder: possible evidence for M3- and M2-dependent components of a motor/sensory system.
    Finney SM; Stewart LH; Gillespie JI
    BJU Int; 2007 Sep; 100(3):668-78. PubMed ID: 17627783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential signalling pathways involved in cholinoceptor-dependent stimulation of nitric oxide isoforms in dental pulp.
    Sterin-Borda L; Furlan C; Reina S; Orman B; Borda E
    Int Endod J; 2007 Jul; 40(7):544-52. PubMed ID: 17511785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholinergic stimulation of amylase secretion from pancreatic acinar cells studied with muscarinic acetylcholine receptor mutant mice.
    Gautam D; Han SJ; Heard TS; Cui Y; Miller G; Bloodworth L; Wess J
    J Pharmacol Exp Ther; 2005 Jun; 313(3):995-1002. PubMed ID: 15764735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells.
    Casanova M; Furlán C; Sterin-Borda L; Borda ES
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):293-301. PubMed ID: 16879495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line.
    Cabadak H; Küçükibrahimoğlu E; Aydin B; Kan B; Zafer Gören M
    Auton Autacoid Pharmacol; 2009 Jul; 29(3):109-15. PubMed ID: 19364336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide synthase-cyclooxygenase interactions are involved in tumor cell angiogenesis and migration.
    Davel L; D'Agostino A; Español A; Jasnis MA; Lauría de Cidre L; de Lustig ES; Sales ME
    J Biol Regul Homeost Agents; 2002; 16(3):181-9. PubMed ID: 12462194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. M2, M3, and M4 muscarinic receptors are expressed in the guinea pig gallbladder.
    Cabadak H; Cuadra AE; El-Fakahany EE; Kan B
    J Recept Signal Transduct Res; 2009; 29(1):63-6. PubMed ID: 19519171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signal transduction pathways of muscarinic receptor mediated activation in the newborn and adult mouse urinary bladder.
    Ekman M; Andersson KE; Arner A
    BJU Int; 2009 Jan; 103(1):90-7. PubMed ID: 18727613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
    Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
    Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
    Kim SH; Kim SH; Song YC; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic submandibular effects and muscarinic receptor expression in blood vessels of the rat.
    Ryberg AT; Selberg H; Soukup O; Gradin K; Tobin G
    Arch Oral Biol; 2008 Jul; 53(7):605-16. PubMed ID: 18329001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parasympathetic modulation of local acute inflammation in murine submandibular glands.
    Español AJ; de la Torre E; Sales ME
    Inflammation; 2003 Apr; 27(2):97-105. PubMed ID: 12797549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
    Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
    Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and function of muscarinic receptor subtypes on human cornea and conjunctiva.
    Liu S; Li J; Tan DT; Beuerman RW
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2987-96. PubMed ID: 17591863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin G from breast cancer patients in stage I stimulates muscarinic acetylcholine receptors in MCF7 cells and induces proliferation. Participation of nitric oxide synthase-derived nitric oxide.
    Negroni MP; Fiszman GL; Azar ME; Morgado CC; Español AJ; Pelegrina LT; de la Torre E; Sales ME
    J Clin Immunol; 2010 May; 30(3):474-84. PubMed ID: 20157846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.